methoxamine has been researched along with bibp 3226 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bischoff, A; Freund, A; Michel, MC | 1 |
1 other study(ies) available for methoxamine and bibp 3226
| Article | Year |
|---|---|
The Y1 antagonist BIBP 3226 inhibits potentiation of methoxamine-induced vasoconstriction by neuropeptide Y.
Topics: Animals; Arginine; Drug Synergism; Hemodynamics; Male; Methoxamine; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Vasoconstriction; Vasoconstrictor Agents | 1997 |